The prion-like protein Doppel: A soluble biomarker steering ovarian cancer’s peritoneal to circulatory dissemination
Preprint
Abstract
Detecting ovarian cancer (OC) early using existing biomarkers, e.g., cancer antigen 125 (CA125), is challenging due to its ubiquitous expression in many tissues. Doppel, a prion-like protein, expresses in male reproductive organ but absent in female reproductive systems and healthy tissues, but plays an important role in neoangiogenesis. Here, we have shown two platforms, soluble Doppel in sera/ascites and Doppel expressed circulating tumor cells ( Dpl+ CTC) in the whole blood, to detect subsets of epithelial OC (EOC). Increased level of Doppel in the sera of OC patients, in three different cohorts, confirm Doppel as OC specific biomarker. Serum Doppel level distinguishes EOC subtypes and early stages HGSOCs from non-cancerous conditions with high sensitivity and specificity. Stratifying the EOCs based on Doppel level, we categorized them into Doppel-high (Dpl hi ) and Doppel-low (Dpl low ) groups. Using ascites-derived organoids and single cell sequencing of whole ascites of Dpl hi and Dpl low patients, we identify that Doppel induces epithelial-mesenchymal transition (EMT) and creates an immunosuppressive microenvironment, respectively. Doppel levels in the sera/ascites correlate with the changes of Dpl+ CTC number in whole blood, highlighting the association of Doppel-induced EMT with CTC dissemination in circulation. Thus, Doppel-based detection of EOC subtypes could be a promising platform as clinical biomarker and link Doppel-axis with OC dissemination.Keywords
This publication has 31 references indexed in Scilit:
- Development and validation of an interpretable model integrating multimodal information for improving ovarian cancer diagnosisNature Communications, 2024
- Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancerBritish Journal of Cancer, 2024
- A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoidsDevelopmental Cell, 2023
- Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialThe Lancet, 2021
- The untapped potential of ascites in ovarian cancer research and treatmentBritish Journal of Cancer, 2020
- Aberrant SERPINE1 DNA methylation is involved in carboplatin induced epithelial-mesenchymal transition in epithelial ovarian cancerArchives of Gynecology and Obstetrics, 2017
- Intra‐abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancerJournal of Surgical Oncology, 2009
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- NMR Structure of the Human Doppel ProteinJournal of Molecular Biology, 2003
- Physiological Expression of the Gene for PrP-Like Protein, PrPLP/Dpl, by Brain Endothelial Cells and its Ectopic Expression in Neurons of PrP-Deficient Mice Ataxic Due to Purkinje Cell DegenerationThe American Journal of Pathology, 2000